Basics India Globalization Capital, Inc. India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. IPO Date: June 1, 2006 Sector: Industrials Industry: Trading Companies and Distributors Market Cap: $39.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 5.50% Avg Daily Range (30 D): $0.01 | 3.64% Avg Daily Range (90 D): $0.01 | 3.74% Institutional Daily Volume Avg Daily Volume: .8M Avg Daily Volume (30 D): .94M Avg Daily Volume (90 D): 1.66M Trade Size Avg Trade Size (Sh.): 344 Avg Trade Size (Sh.) (30 D): 639 Avg Trade Size (Sh.) (90 D): 499 Institutional Trades Total Inst.Trades: 84 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.15M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 473.34K     News Aug 12, 2025 @ 5:00 PM Cannabinoid Clinical Trial Pipeline Gains Momentum... Source: Delveinsight Jul 10, 2025 @ 5:00 PM Cannabinoid Agonist Clinical Trial Pipeline Appear... Source: Delveinsight Jul 6, 2023 @ 12:03 PM Why VBI Vaccines Are Trading Lower By Over 23%; He... Source: Lisa Levin Mar 20, 2023 @ 12:45 PM IGC Announces Rebranding, Changes Name to IGC Pha... Source: IGC Pharma, Inc. Feb 15, 2023 @ 12:41 AM IGC Reports Financial Results for Third Fiscal Qua... Source: INDIA GLOBALIZATION CAPITAL INC. Financials   TTM Q1 2026 Q4 2025 Basic EPS $-.07 $-.02 Diluted EPS $-.07 $-.02 Revenue $ 1.33M $ .33M $ Gross Profit $ .61M $ .15M $ Net Income / Loss $ -6.34M $ -1.6M $ Operating Income / Loss $ -6.96M $ -1.91M $ Cost of Revenue $ .72M $ .17M $ Net Cash Flow $ -1.39M $ .02M $ PE Ratio     Splits Apr 19, 2013:   1:10